CanBas Co.,Ltd.

4575

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-12FY2026

Revenue

YoY -

Operating Income

-13.6100M JPY

YoY -22.4%

Net Income

-13.1100M JPY

YoY -13.0%

EPS

-66.4JPY

YoY -8.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

-3.4億円

-6.8億円

-10.2億円

-13.6億円

Rev: -Op: -8.5億円NI: -8.6億円

Rev: -Op: -9.7億円NI: -12.4億円

Rev: -Op: -12.6億円NI: -12.1億円

Rev: -Op: -11.1億円NI: -11.6億円

Rev: -Op: -13.6億円NI: -13.1億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Achievement

FY2026

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Achieved-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan